Search by Drug Name or NDC

    NDC 52343-0053-05 Pioglitazone Hydrochloride 15 mg/1 Details

    Pioglitazone Hydrochloride 15 mg/1

    Pioglitazone Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ACETRIS HEALTH, LLC. The primary component is PIOGLITAZONE HYDROCHLORIDE.

    Product Information

    NDC 52343-0053
    Product ID 52343-053_62b88c63-8045-4a1e-92b1-4ae0cc6a8354
    Associated GPIs 27607050100320
    GCN Sequence Number 042943
    GCN Sequence Number Description pioglitazone HCl TABLET 15 MG ORAL
    HIC3 C4N
    HIC3 Description ANTIHYPERGLYCEMIC,THIAZOLIDINEDIONE(PPARG AGONIST)
    GCN 92991
    HICL Sequence Number 020324
    HICL Sequence Number Description PIOGLITAZONE HCL
    Brand/Generic Generic
    Proprietary Name Pioglitazone Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Pioglitazone Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name PIOGLITAZONE HYDROCHLORIDE
    Labeler Name ACETRIS HEALTH, LLC
    Pharmaceutical Class PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200268
    Listing Certified Through 2023-12-31

    Package

    NDC 52343-0053-05 (52343005305)

    NDC Package Code 52343-053-05
    Billing NDC 52343005305
    Package 500 TABLET in 1 BOTTLE (52343-053-05)
    Marketing Start Date 2013-02-13
    NDC Exclude Flag N
    Pricing Information N/A